Successful treatment of refractory eosinophilic fasciitis with reslizumab
Main Authors: | Mahta Mortezavi, MD, Mary Barrett, MD, Mohammadomid Edrissian, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512620305488 |
Similar Items
-
Role of biologics in severe eosinophilic asthma – focus on reslizumab
by: Pelaia G, et al.
Published: (2016-07-01) -
Eosinophilic fasciitis in association with nivolumab: The importance of eosinophilia
by: Gabriela Pabón-Cartagena, MD, et al.
Published: (2020-12-01) -
A “groovy” diagnosis: Eosinophilic fasciitis
by: Peter Korsten
Published: (2020-12-01) -
Eosinophilic Fasciitis: an Atypical Presentation of a Rare Disease
by: Sabrina Poradosu, et al.
Published: (2015-04-01) -
Reslizumab versus placebo for poorly controlled, severe eosinophilic asthma: Meta-analysis
by: Milosavljević Miloš N., et al.
Published: (2018-01-01)